UK: Matt Hancock MP hosts UK Governments daily coronavirus briefing, Part Six.

The video discusses the discovery and support of promising vaccine projects, highlighting the Imperial vaccine's progress to human trials and Astra Zeneca's manufacturing deal for the Oxford vaccine. It emphasizes the strategy of manufacturing vaccines ahead of approval to ensure readiness, similar to the approach taken with dexamethasone. Additionally, it outlines the proposed prioritization plan for vaccine access once available.

Which vaccine has recently entered the first phase of human clinical trials?

• Moderna vaccine

• Imperial vaccine

• Pfizer vaccine

• Johnson & Johnson vaccine

What is AstraZeneca's role in the development of the Oxford vaccine?

• Conducting clinical trials

• Researching vaccine efficacy

• Manufacturing the vaccine

• Distributing the vaccine

Why is the Oxford vaccine being manufactured ahead of approval?

• To test its effectiveness

• To ensure availability upon approval

• To reduce production costs

• To distribute it globally

What was stockpiled before its clinical effectiveness was proven, similar to the Oxford vaccine strategy?

• Convalescent plasma

• Dexamethasone

• Remdesivir

• Hydroxychloroquine

What has been published regarding vaccine distribution once a vaccine is available?

• A list of approved vaccines

• A timeline for vaccine production

• A global distribution strategy

• A prioritization plan for vaccine access